AEG-1 is associated with tumor progression in nonmuscle-invasive bladder cancer

被引:0
|
作者
Guoliang Yang
Lianhua Zhang
Shilong Lin
Linfeng Li
Mengyao Liu
Haige Chen
Ming Cao
Dongming Liu
Yi-ran Huang
Juanjie Bo
机构
[1] Shanghai Jiao Tong University,Department of Urology, Ren Ji Hospital
[2] Shanghai Jiao Tong University,Clinical Stem Cell Research Center, Ren Ji Hospital
来源
Medical Oncology | 2014年 / 31卷
关键词
AEG-1; Bladder cancer; Prognosis; Progression;
D O I
暂无
中图分类号
学科分类号
摘要
Astrocyte elevated gene-1 (AEG-1), a novel oncoprotein, has been implicated in oncogenesis and cancer progression in various types of human cancers. Here, immunohistochemistry was used to detect AEG-1 expression in nonmuscle-invasive bladder cancer (NMIBC), and these data were examined for correlation with clinicopathological parameters, and prognosis. Immunohistochemical analysis revealed that AEG-1 expression was significantly higher in bladder cancer tissues than that in normal tissues. High expression of AEG-1 was found in 45 % of bladder cancers and significantly associated with tumor grade (P = 0.002) and progression (P = 0.028). The Kaplan–Meier survival analysis demonstrated that AEG-1 expression was significantly associated with shorter progression-free survival (P = 0.0011). Multivariate analysis further demonstrated that AEG-1 was an independent prognostic factor for patients with BC. AEG-1 protein may contribute to the malignant progression of bladder cancer, and present as a novel marker to predict the progression of NMIBC.
引用
收藏
相关论文
共 50 条
  • [1] AEG-1 is associated with tumor progression in nonmuscle-invasive bladder cancer
    Yang, Guoliang
    Zhang, Lianhua
    Lin, Shilong
    Li, Linfeng
    Liu, Mengyao
    Chen, Haige
    Cao, Ming
    Liu, Dongming
    Huang, Yi-ran
    Bo, Juanjie
    MEDICAL ONCOLOGY, 2014, 31 (06)
  • [2] Nonmuscle-invasive bladder cancer
    vom Dorp, F.
    Luemmen, G.
    Ruebben, H.
    UROLOGE, 2015, 54 (04): : 479 - 479
  • [3] Perioperative management of nonmuscle-invasive bladder cancer
    Falke, Johannes
    Witjes, J. Alfred
    CURRENT OPINION IN UROLOGY, 2011, 21 (05) : 403 - 408
  • [4] Study for the Therapy of nonmuscle-invasive Bladder Cancer
    Rexer, H.
    UROLOGE, 2014, 53 (06): : 890 - 892
  • [5] Rethinking the Treatment of Recurrent Nonmuscle-Invasive Bladder Cancer
    Schoenberg, Mark
    Steinberg, Gary
    JOURNAL OF UROLOGY, 2021, 206 (01): : 7 - 9
  • [6] Clinical pitfalls in diagnosis of nonmuscle-invasive bladder cancer
    Serretta, Vincenzo
    Gesolfo, Cristina Scalici
    UROLOGIA JOURNAL, 2015, 82 : S1 - S4
  • [7] Genomic landscape of micropapillary nonmuscle-invasive bladder cancer
    Reardon, Brendan
    Mullane, Stephanie A.
    Kim, Jaegil
    Getz, Gad
    Orsola, Anna
    Kwiatkowski, David J.
    Van Allen, Eliezer Mendel
    Bellmunt, Joaquim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] SURVIVORSHIP AND THE NEED FOR CANCER NAVIGATION IN NONMUSCLE-INVASIVE BLADDER CANCER
    Honore, Heather H.
    Amiel, Gilad E.
    Lerner, Seth P.
    Latini, David M.
    ANNALS OF BEHAVIORAL MEDICINE, 2010, 39 : 57 - 57
  • [10] Update on the role of endovesical chemotherapy in nonmuscle-invasive bladder cancer
    Unda-Urzaiz, M.
    Fernandez-Gomez, J. M.
    Cozar-Olmos, J. M.
    Juarez, A.
    Palou, J.
    Martinez-Pineiro, L.
    ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (02): : 73 - 76